ATE71843T1 - Behandlung des atemunwohlseinsyndroms bei erwachsenen. - Google Patents

Behandlung des atemunwohlseinsyndroms bei erwachsenen.

Info

Publication number
ATE71843T1
ATE71843T1 AT86902635T AT86902635T ATE71843T1 AT E71843 T1 ATE71843 T1 AT E71843T1 AT 86902635 T AT86902635 T AT 86902635T AT 86902635 T AT86902635 T AT 86902635T AT E71843 T1 ATE71843 T1 AT E71843T1
Authority
AT
Austria
Prior art keywords
syndrome
wellbeing
adults
respiratory
treatment
Prior art date
Application number
AT86902635T
Other languages
English (en)
Inventor
Thomas A Raffin
John H Stevens
Original Assignee
Thomas A Raffin
John H Stevens
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomas A Raffin, John H Stevens filed Critical Thomas A Raffin
Application granted granted Critical
Publication of ATE71843T1 publication Critical patent/ATE71843T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT86902635T 1985-04-02 1986-03-31 Behandlung des atemunwohlseinsyndroms bei erwachsenen. ATE71843T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US06/718,918 US4686100A (en) 1985-04-02 1985-04-02 Method for the treatment of adult respiratory distress syndrome
PCT/US1986/000659 WO1986005692A2 (en) 1985-04-02 1986-03-31 Treatment of adult respiratory distress syndrome
EP86902635A EP0219524B1 (de) 1985-04-02 1986-03-31 Behandlung des atemunwohlseinsyndroms bei erwachsenen

Publications (1)

Publication Number Publication Date
ATE71843T1 true ATE71843T1 (de) 1992-02-15

Family

ID=24888089

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86902635T ATE71843T1 (de) 1985-04-02 1986-03-31 Behandlung des atemunwohlseinsyndroms bei erwachsenen.

Country Status (6)

Country Link
US (1) US4686100A (de)
EP (1) EP0219524B1 (de)
JP (1) JPS62502616A (de)
AT (1) ATE71843T1 (de)
DE (1) DE3683586D1 (de)
WO (1) WO1986005692A2 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5147637A (en) * 1988-06-07 1992-09-15 The Rockefeller University Method of inhibiting the influx of leukocytes into organs during sepsis or other trauma
US4966137A (en) * 1989-09-19 1990-10-30 Davini Mark A Splint system
US5322699A (en) * 1991-02-04 1994-06-21 The Rockefeller University Leukocyte-derived CR3 modulator, integrin modulating factor-1 (IMF-1)
EP0523856A3 (en) * 1991-06-28 1993-03-17 Sgs-Thomson Microelectronics, Inc. Method of via formation for multilevel interconnect integrated circuits
WO1993011784A1 (en) * 1991-12-13 1993-06-24 Duke University Methods for inhibition or stimulation of the inflammatory response
US5807824A (en) * 1993-12-06 1998-09-15 Ciba-Geigy Corporation C5A receptor antagonists having substantially no agonist activity
US5837499A (en) * 1993-12-06 1998-11-17 Ciba-Geigy Corporation DNA encoding C5A receptor antagonists having substantially no agonist activity and methods of expressing same
ES2236706T3 (es) * 1994-03-23 2005-07-16 Alexion Pharmaceuticals, Inc. Procedimiento para reducir las disfunciones de los sistemas inmunitario y hemostatico durante la circulacion extracorporal.
US5504090A (en) * 1994-03-30 1996-04-02 Trustees Of The University Of Pennsylvania Compositions and methods for the prevention and treatment of ischemia-reperfusion organ injury
US6074642A (en) 1994-05-02 2000-06-13 Alexion Pharmaceuticals, Inc. Use of antibodies specific to human complement component C5 for the treatment of glomerulonephritis
US5504111A (en) * 1994-12-30 1996-04-02 Medichem Research, Inc. Use of 2,3 alkylcarbonyloxybenzoic acid in treating adult respiratory distress syndrome
WO1997032585A1 (en) * 1996-03-05 1997-09-12 Medinox, Inc. Combinational therapeutic methods employing nitric oxide scavengers and compositions useful therefor
US6673346B1 (en) * 1999-08-31 2004-01-06 The Regents Of The University Of Michigan Compositions and methods for the treatment of sepsis
CA2457461C (en) 2001-08-17 2013-12-24 Tanox, Inc. Complement pathway inhibitors binding to c5 and c5a without preventing the formation of c5b
EP1878441B1 (de) 2001-08-17 2018-01-24 Genentech, Inc. Komplement-Inhibitoren, die an C5 und C5a binden, ohne die Bildung von C5b zu hemmen
NZ538384A (en) 2002-09-06 2009-04-30 Alexion Pharma Inc Treatment for asthma using a compound which binds to or otherwise blocks the generation and/or activity of one or more complement components reptors, such as, C5a receptors
US20050169921A1 (en) 2004-02-03 2005-08-04 Leonard Bell Method of treating hemolytic disease
US20070116710A1 (en) * 2004-02-03 2007-05-24 Leonard Bell Methods of treating hemolytic anemia
US20070196367A1 (en) * 2006-02-22 2007-08-23 Valentin Dinu Methods of preventing and treating Alzheimer's disease, age related macular degeneration and other diseases involving extra-cellular debris through the inhibition of the complement system
BRPI0708909B8 (pt) 2006-03-15 2021-05-25 Alexion Pharma Inc uso de um anticorpo que se liga a c5 para tratar um paciente que sofre de hemoglobinúria paroxística noturna
WO2010054403A1 (en) 2008-11-10 2010-05-14 Alexion Pharmaceuticals, Inc. Methods and compositions for treating complement-associated disorders
PT3078658T (pt) 2008-12-22 2019-07-16 Chemocentryx Inc Antagonistas do c5ar
NZ603226A (en) 2010-04-30 2015-02-27 Alexion Pharma Inc Anti-c5a antibodies and methods for using the antibodies
ES2632975T3 (es) 2010-06-24 2017-09-18 Chemocentryx, Inc. Antagonistas de C5aR
EP2468295A1 (de) 2010-12-21 2012-06-27 Affiris AG Impfstoffe basierend auf Komplementprotein C5a Peptide
KR102192596B1 (ko) 2013-08-07 2020-12-18 알렉시온 파마슈티칼스, 인코포레이티드 비정형적 용혈성 요독증후군 (ahus) 바이오마커 단백질
PL3200791T3 (pl) 2014-09-29 2020-08-10 Chemocentryx, Inc. Sposoby i produkty pośrednie w otrzymywaniu antagonistów C5AR
CN108601790A (zh) 2016-01-14 2018-09-28 凯莫森特里克斯股份有限公司 C3肾小球病的治疗方法
MY196220A (en) 2016-06-14 2023-03-23 Regeneron Pharma Anti-C5 Antibodies and uses Thereof
WO2019118556A1 (en) 2017-12-13 2019-06-20 Regeneron Pharmaceuticals, Inc. Anti-c5 antibody combinations and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3407M (fr) * 1964-03-25 1965-07-05 Michel Plissier Immunoglobulines anti-antigenes microbiens et viraux, seules ou associées, utilisées dans la prévention et le traitement des syndromes infectieux respiratoires.

Also Published As

Publication number Publication date
JPS62502616A (ja) 1987-10-08
EP0219524B1 (de) 1992-01-22
US4686100A (en) 1987-08-11
WO1986005692A2 (en) 1986-10-09
EP0219524A1 (de) 1987-04-29
DE3683586D1 (de) 1992-03-05

Similar Documents

Publication Publication Date Title
ATE71843T1 (de) Behandlung des atemunwohlseinsyndroms bei erwachsenen.
DE69020582T2 (de) Verwendung von Melatonin zur Behandlung des prämenstruellen Syndroms.
ATE258065T1 (de) Behandlung von autoimmun-erkrankungen durch orale verabreichung von autoantigenen
DE69132688T2 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
HK45193A (en) Ozone decontamination of blood and blood products
DE68917219T2 (de) Therapeutisches Erzeugnis zur Behandlung von Beschwerden während der oder nach den Wechseljahren.
RU94020410A (ru) Способ лечения или профилактики рвоты у млекопитающих и человека с использованием некоторых хинуклидиновых, пиперидиновых, азанорборнановых, этилендиаминовых производных и родственных им соединений
ATE78696T1 (de) Arzneimittelzubereitung zur behandlung des immunmangels.
ES8503643A1 (es) Un procedimiento para la preparacion de compuestos de bis (carboxamida)
ES2058343T3 (es) Piridinas disubstituidas.
DE3854121D1 (de) Arzneimittelzusammensetzungen zur behandlung von psoriasis.
IT8548055A1 (it) Composizioni farmaceutiche per la terapia di sindromi cerebrali involutive e del decadimento mentale
ATE115863T1 (de) Verwendung eines immunglobulinhaltigen präparates zur prophylaxe und therapie von aids beim menschen.
ATE204476T1 (de) Verwendung von 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazi e zur herstrllung eines medikaments zur behandlung von bestimmten schmerzen und ödem
ZA814902B (en) Novel thiazol-2-yl-oxamic acid derivatives,their preparation and therapeutic agents containing these compounds
DE3879837T2 (de) Pharmazeutische praeparate zur behandlung von zereberalen psycho-organischen syndromen.
ATE136776T1 (de) Verwendung von heptastigmin zur behandlung der zerebralen ictus
PT86794A (pt) Process for the preparation of compositions for the treatment of wood and processes of treating wood
NO900044D0 (no) Hemorroidale, andre blandinger og metoder for behandling.
ATE84435T1 (de) Einrichtung zur behandlung von gasen.
UA19938A1 (uk) Спосіб лікуваhhя уражеhь кістhої системи при гострому лейкозі у дітей
DE69116452D1 (de) Verwendung von 3-Oxygermylpropionsäure zur Behandlung des Erkältungssyndroms
ATE101054T1 (de) Einrichtung zur diagnostik und behandlung von nasenerkrankungen.
DK563886A (da) Terapeutisk komposition
ATE91626T1 (de) Pyridin- oder pyridazinderivate als kardioprotektiva und zur behandlung von ischaemischen beschwerden und herstellungsprozess.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties